|کد مقاله||کد نشریه||سال انتشار||مقاله انگلیسی||ترجمه فارسی||نسخه تمام متن|
|5124200||1378440||2017||7 صفحه PDF||ندارد||دانلود کنید|
SummaryObjectiveTo develop a French version of the Reflux Symptom Index (Fr-RSI) and to assess its internal consistency, reliability, and clinical validity.Study DesignControlled, prospective trial.Materials and MethodsForty-four patients with a reflux finding score >â7 and an Fr-RSIâ>â13 were enrolled and treated with 20âmg of pantoprazole twice daily and diet changes for 3 months. Ninety asymptomatic subjects were also included in the study. To assess reliability, Fr-RSI was completed twice within a 7-day period. Validity was assessed by comparing Fr-RSI scores with scores from the Voice Handicap Index (VHI) in 24 of 44 patients, at baseline and at 3Â months posttherapy.ResultsThe mean values of Fr-RSI at baseline and after 7 days were 20.17âÂ±â5.76 and 19.75âÂ±â7.08, respectively, for patients with laryngopharyngeal reflux (LPR) and 4.02âÂ±â3.49 and 3.71âÂ±â3.82, respectively, for controls. The test-retest reliability was high in patients with LPR (rBPâ=â0.78) and in healthy subjects (rBPâ=â0.80). Cronbach's alpha was 0.85, indicating high internal consistency. The mean Fr-RSI score significantly improved from a baseline of 20.17âÂ±â5.76 to 5.58âÂ±â3.65 after 3 months of treatment (Pâ=â0.001), and the initial mean VHI total score significantly improved from 20.29âÂ±â19.62 to 12.87âÂ±â12.04 after treatment (Pâ=â0.029), indicating validity of the results. However, of the subcategories of the VHI, only the mean physical score improved from a baseline of 11.19âÂ±â9.22 to 7.35âÂ±â5.96 after treatment (Pâ=â0.016).ConclusionThe Fr-RSI developed in this study demonstrated both reliability and validity. It can be easily administered to assist in diagnosing and monitoring of LPR in French-speaking patients.
Journal: Journal of Voice - Volume 31, Issue 4, July 2017, Pages 512.e1-512.e7